Vivitra 150mg Injection

About Vivitra 150mg Injection

Vivitra 150 mg Injection contains trastuzumab, a targeted monoclonal antibody used to treat HER2-positive breast and gastric cancers. It works by binding to the HER2 receptor on cancer cells, blocking growth signals and slowing the spread and replication of cancer cells.

Vivitra is administered as an intravenous (IV) infusion by a healthcare professional, usually once weekly or every three weeks based on the treatment plan. Common side effects include fever, headache, cough, rash, infections, and sleep disturbances, while serious risks may include heart problems, allergic reactions, or lung complications. Heart function and vital signs are closely monitored during treatment, and its use during pregnancy requires strict medical supervision.